Form 4: Pfizer Director Mortimer Buckley Reports Stock Transactions

Pfizer Inc. director Mortimer J. Buckley has reported transactions involving phantom stock units, settling deferred compensation.

Summary

• Mortimer J. Buckley, a Director at Pfizer Inc., has filed a Form 4 reporting transactions related to phantom stock units.
• The transactions occurred on June 26, 2026, and involved the acquisition of 1,543.845 phantom stock units.
• These units represent deferred director's compensation, including dividend equivalents.
• The phantom stock units are settled in cash or common stock upon the director's retirement from the Board of Directors.
• Buckley's address is listed as 66 Hudson Boulevard East, New York, NY 10001-2192.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents a standard disclosure of deferred compensation settlement rather than a new investment or divestment decision by a company insider.

Positives

• Director compensation plan is in place, indicating a structured approach to director remuneration.
• Deferred compensation plan allows for potential future stock ownership or cash settlement, aligning director interests with the company's long-term performance.

Negatives

• The filing details a transaction related to deferred compensation rather than a purchase of stock with personal funds, which might be perceived as less of a direct investment signal.

Risks

• The value of the phantom stock units is subject to fluctuations in Pfizer's common stock price.
• Settlement of these units is contingent upon the reporting person's retirement from the Board of Directors.

Future Outlook

The future outlook for the phantom stock units is tied to the settlement upon retirement, which can be in cash or common stock, and is dependent on the future performance of Pfizer's stock.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions in the pharmaceutical industry, providing transparency on executive and director compensation and potential stock holdings.

Related Party Transactions

• The reported transaction involves deferred director's compensation, which is a form of related party transaction between the company and its director.

Stakeholder Impact

• Shareholders: Increased transparency regarding director compensation and potential future dilution if settled in stock.
• Employees: May observe standard executive compensation practices within the company.
• Management: Reinforces the structure of director remuneration.

Next Steps

• Settlement of phantom stock units in cash or common stock upon Mortimer J. Buckley's retirement from the Board of Directors.

Key Dates

Keywords

Pfizer Inc., PFE, Form 4, SEC Filing, Director, Mortimer J. Buckley, Phantom Stock Units, Deferred Compensation, Beneficial Ownership, Insider Transaction